SwedenResearch and clinical trials
40 years of laboratory data in Sweden: Zellweger spectrum occurs in about one in 74 thousand births
All patients diagnosed with a peroxisomal disorder in Sweden were studied.
Inborn errors of metabolism
An inherited disease of a structure inside the cells. Tiny sacs called peroxisomes do not form properly. The brain, liver, sight and hearing can be affected.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
This page is translated from the Turkish original.
This disease is followed through the “Inborn errors of metabolism” group.
Peroxisomes are tiny sacs inside the cell that break down certain fats and harmful substances. In this disease, peroxisomes do not form at all or work poorly. Very long-chain fats build up. The brain, liver, kidneys, eyes and ears can be affected. There are severe, intermediate and mild forms.
Symptoms vary greatly from person to person. In the severe form they begin at birth; in the mild form they begin later.
The first step is to measure very long-chain fats in the blood. Other peroxisome tests are also done on blood and urine. The diagnosis is confirmed with a genetic test.
Care focuses on the symptoms and is the work of a team. Hearing aids, glasses and cataract surgery can help. A feeding tube into the stomach may be needed. Supplements of fat-soluble vitamins may be used. In the USA, there is an approved bile acid treatment for peroxisome disorders. The adrenal glands, bones and teeth are checked regularly. Early special education and physiotherapy are important. The doctor who follows the disease decides which treatment is suitable.
The disease is passed on through recessive inheritance. The mother and father are usually healthy carriers. For a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. If the gene change is known, diagnosis during pregnancy is possible. Genetic counselling is recommended for the family.
Source: MedlinePlus Genetics: Zellweger spectrum disorder · NORD: Zellweger Spectrum Disorders · Orphanet: Peroxisome biogenesis disorder-Zellweger spectrum (ORPHA:79189)
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
SwedenResearch and clinical trials
All patients diagnosed with a peroxisomal disorder in Sweden were studied.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
Questions you can ask your doctor
ClinicalTrials.gov lists 1 active interventional study for this disease. None is recruiting right now; none has a site in Türkiye. Last checked: October 7, 2026.
Selected records (studies with a site in Türkiye first):
Middle stage: the effect is being tested in a small group · Phase 2 · investigational (experimental)Active, not recruitingNCT02171104
See all studies on ClinicalTrials.gov · Joining clinical trials
EUNew treatments and approvals
In Europe, leriglitazone, taken by mouth, was authorized for cerebral adrenoleukodystrophy.
USANew treatments and approvals
Through the accelerated pathway, the FDA has approved pariglasgene brecaparvovec for glycogen storage disease type Ia.
EuropeResearch and clinical trials
A total of 58 patients from 34 centers in seven European countries were followed.
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:79189 · ICD-11 5C57.0
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.